References
- Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982; 248: 1465–1477
- Ames R P, Hill P. Antihypertensive therapy and the risk of coronary heart disease. J Cardiovasc Pharmacol 1982; 2: 206–212, Suppl
- Groop L, Totterman K-J, Harno K, Gordin A. Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Acta Med Scand 1982; 211: 7–12
- Cressman M D, Vidt D G, Mohler H, Gifford R W, Jr. Glucose tolerance during chronic propranolol treatment. J Clin Hypertens 1985; 2: 138–144
- Weinberger M H. Influence of an angiotensin converting-enzyme inhibitor on diuretics-induced metabolic effects in hypertension. Hypertension 1983; 5(Suppl III)132–138
- Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617–1620
- Shionoiri H, Miyakawa T, Takasaki I, Ishikawa Y, Hiroto S, Kaneko Y, Shindo Y. Glucose tolerance during chronic captopril therapy in patients with essential hypertension. J Cardiovasc Pharmacol 1987, in press, Jan/Feb